Report. JAMA

:

–

Wang JY, Yan SK, Chen BS, Xue H, et al. (2004) Genetic effect of two

Amdam GV, Simoes ZLP, Hagen A, Norberg K, Schroder K, et al. (

) Hormonal control of the yolk precursor vitellogenin regulates immune function and longevity in honeybees. Exp Gerontol

:

–

Rincon M, Muzumdar R, Atzmon G, Barzilai N (

) The paradox of the insulin/IGF-

signaling pathway in longevity. Mech Ageing Dev

:

–

Altomonte J, Cong L, Harbaran S, Richter A, Xu J, et al. (

) Foxo

mediates insulin action on ap

-III and triglyceride metabolism. J Clin Invest

:

–

Ostrer H (

) A Genetic Profile of Contemporary Jewish Populations. Nat Rev Genet

:

–

Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, et al. (

) The Risk of Cancer Associated with Specific Mutations of BRCA

and BRCA

among Ashkenazi Jews. N Engl J Med

:

–

Foulkes WD, Chappuis PO, Wong N, Brunet JS, Vesprini D, et al. (

) Primary node negative breast cancer in BRCA

mutation carriers has a poor outcome. Ann Oncol

:

–

Friedrichsen DM, Stanford JL, Isaacs SD, Janer M, Chang BL, et al. (

) Identification of a prostate cancer susceptibility locus on chromosome

q

–

in Jewish families. PNAS

:

–

Kadouri L, Kote-Jarai Z, Hubert A, Durocher F, Abeliovich D, et al. (

) A single-nucleotide polymorphism in the RAD

gene modifies breast cancer risk in BRCA

carriers, but not in BRCA

carriers or noncarriers. Br J Cancer

:

–

Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, et al. (

) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA

Science

:

–

Abeliovich D, Kaduri L, Lerer I, Weinberg N, Amir G, et al. (

) The founder mutations

de

G and

in

in BRCA

and

de

in BRCA

appear in

% of ovarian cancer and

% of early-onset breast cancer patients among Ashkenazi women. Am J Hum Genet

:

–

Meiner V, Landsberger D, Berkman N, Reshef A, Segal P, et al. (

) A common Lithuanian mutation causing familial hypercholesterolemia in Ashkenazi Jews. Am J Hum Genet

:

–

Verghese J, Lipton RB, Katz MJ, Hall CB, Derby CA, et al. (

) Leisure activities and the risk of dementia in the elderly. N Engl J Med

:

–

Cheng S, Grow MA, Pallaud C, Klitz W, Erlich HA, et al. (

) A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res

:

–

Pascot A, Lemieux I, Bergeron J, Tremblay A, Nadeau A, et al. (

) HDL particle size: A marker of the gender difference in the metabolic risk profile. Atherosclerosis

:

–

Price JF, Fowkes FG (

) Risk factors and the sex differential in coronary artery disease. Epidemiology

:

–

Barrett JC, Fry B, Maller J, Daly MJ (

) Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics

:

–

on serum lipids and lipoproteins levels in a Chinese population. Clin Genet

:

–

Olivieri O, Martinelli N, Sandri M, Bassi A, Guarini P, et al. (

) Apolipoprotein C-III, n-

polyunsaturated fatty acids, and ‘‘insulin- resistant’’ T-

C APOC

gene polymorphism in heart Disease Patients: Example of gene-diet interaction. Clin Chem

:

–

Ito Y, Azrolan N, O’Connell A, Walsh A, Breslow JL (

) Hyper- triglyceridemia as a result of human apo CIII gene expression in transgenic mice. Science

:

–

Maeda N, Li H, Lee D, Oliver P, Quarfordt SH, et al. (

) Targeted disruption of the apolipoprotein C-III gene in mice results in hypotrigly- ceridemia and protection from postprandial hypertriglyceridemia. J Biol Chem

:

–

Takahashi T, Hirano T, Okada K, Adachi M (

) Apolipoprotein CIII deficiency prevents the development of hypertriglyceridemia in strepto- zotocin-induced diabetic mice. Metabolism

:

–

Karathanasis SK (

) Apolipoprotein multigene family: Tandem organ- ization of human apolipoprotein AI, CIII, and AIV genes. Proc Natl Acad Sci U S A

:

–

Garasto S, Rose G, Derango F, Berardelli M, Corsonello A, et al. (

) The study of APOA

, APOC

and APOA

variability in healthy ageing people reveals another paradox in the oldest old subjects. Ann Hum Genet

:

–

Panza F, D’Introno A, Colacicco AM, Capurso C, Capurso S, et al. (

) Vascular genetic factors and human longevity. Mech Ageing Dev

:

–

Dallinga-Thie GM, Groenendijk M, Blom RN, De Bruin TW, De Kant E (

) Genetic heterogeneity in the apolipoprotein C-III promoter and effects of insulin. J Lipid Res

:

–

Li WW, Dammerman MM, Smith JD, Metzger S, Breslow JL, et al. (

) Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceride- mia. J Clin Invest

:

–

Arai Y, Hirose N, Yamamura K, Nakazawa S, Shimizu K, et al. (

) Deficiency of choresteryl ester transfer protein and gene polymorphisms of lipoprotein lipase and hepatic lipase are not associated with longevity. J Mol Med

:

–

Lucchi T, Arosio B, Caloni M, Ceconi I, Calabresi C, et al. (

) [I

V polymorphism of the cholesteryl ester transfer protein gene in young and very old individuals]. Ann Ital Med Int

:

–

Murphy CT, M

arroll SA, Bargmann CI, Fraser A, Kamath RS, et al. (

) Genes that act downstream of DAF-

to influence the lifespan of Caenorhabditis elegans. Nature

:

–

Holzenberger M, Dupont J, Ducos B, Leneuve P, Geloen A, et al. (

) IGF-

receptor regulates lifespan and resistance to oxidative stress in mice. Nature

:

–

Kenyon C (

) A conserved regulatory system for aging. Cell

:

–